News, Policy & Media

27Aug

New Chairman for MHRA

Stephen Lightfoot has been appointed as the Agency’s new Chair from 1st September 2020. He succeeds Prof Sir Michael Rawlins GBE, Kt who has been the Chair of the Agency Board since December 2014.

Stephen has been a Non-Executive Director of the Agency since September 2015 and is also Deputy Chair of Sussex Community NHS Foundation Trust and Non-Executive Chair of Sussex Primary Care Limited.

Before joining the Board, Stephen had a 30-year career in the life sciences industry working on the development and commercialisation of a wide range of medicines and medical devices in UK and global healthcare companies. His most recent executive roles were General Manager of the global pharmaceutical diagnostics business of GE Healthcare, Managing Director of the UK pharmaceutical business of Daiichi Sankyo and Commercial Director of the UK pharmaceutical and medical device business of Schering Healthcare.

BIVDA will be writing to Stephen when he takes up his position to outline the IVD sector's priorities for the MHRA, especially with regard to regulatory regimes post-December 31st when the transition period ends.

Related

The Government announced the start of the new NHS Test and Trace programme yesterday. It comes as&nb...

Read More >

The Department for Business, Energy and Industrial Strategy has provided the following updates to su...

Read More >

The slides from the IVD industry testing webinar co-organised with BIVDA and hosted the Government c...

Read More >

Regular virus testing of care home staff and residents is to begin from this week, to maximise the d...

Read More >

Scotland’s Deputy First Minister, John Swinney, has announced up to £9.5 million of new ...

Read More >

The new Lighthouse Lab in Charnwood, Loughborough has begun operations, processing thousands of COVI...

Read More >